Dear Editor,
We read with interest the article by Kraft Rovere et al. published in the October 2025 issue of Klinická onkologie on cancer patients admitted to intensive care unit – a six-year retrospective analysis [1]. We agree with you that it is difficult to determine whether a seriously ill cancer patient should be admitted to the ICU. When deciding whether to admit cancer patients to the ICU for intensive therapy, it is necessary to consider not only whether their life can be saved, but also whether cancer treatment can be continued after ICU treatment. We would appreciate if you could let us know about this point in the cancer patients examined in this study. In particular, as you pointed out, how has the aging population affected ICU therapy for cancer patients? Have there been any changes over time? Please let us know about these points. As the authors described at the end of the discussion, we do agree with your opinion that evaluation of the anti-cancer treatment being administered, the response to treatment, the patient‘s prognosis considering the cancer, and the reversibility of the acute illness are important for admission of IUC therapy in cancer patients. Future studies investigating these items will likely be published. Such information will be important for evaluating the quality of medical care at facilities and for maintaining that quality in the future. We would appreciate if you could build on your results and tell us how else these important findings can be used.
Reference
- Kraft Rovere R, Pires de Souza ME, Rodrigues Chamse Ddine Y et al. Cancer patients admitted to intensive care unit – a six-year retrospective analysis. Klin Onkol 2025; 38 (5): 381–385. doi: 10.48095/ccko2025381.
